Biopharmaceutical CMO and CRO Market Size and Forecasts (2021 - 2031), Global and Regional Share, Trends, and Growth Opportunity Analysis

Coverage: Biopharmaceutical CMO and CRO Market covers analysis By Source (Mammalian, Non-Mammalian); Service Type (Contract Manufacturing, Contract Research); Product (Biologics, Biosimilars) , and Geography (North America, Europe, Asia Pacific, and South and Central America)

Publication Month : Mar 2024

  • Report Code : TIPRE00007162
  • Category : Healthcare IT
  • Status : Upcoming
  • No. of Pages : 150
Inquire Before Buy

PRICING

$5190

$4671

MARKET OVERVIEW

A contract research organization (CRO) is an enterprise that offers research and development services to the pharmaceutical and biotechnology industries. These companies collaborate with other companies to arrange and conduct clinical trials in order to test the novel molecule before it is approved. Contract manufacturing organizations (CMOs) provide manufacturing services in a range of volumes, from small amounts for preclinical research and development to larger volumes required for clinical trials and commercialization.

MARKET SCOPE

The Global Biopharmaceutical CMO And CRO Market Analysis to 2028 is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of the biopharmaceutical CMO and CRO market with detailed market segmentation by source, service type and product. The report provides key statistics on the market status of the leading biopharmaceutical CMO and CRO market players and offers key trends and opportunities in the market.

MARKET SEGMENTATION

  •   Based on source the market is segmented as, mammalian and non-mammalian.
  •   Based on service type the market is segmented as, contract manufacturing and contract research.
  •   Based on product the market is bifurcated as, biologics and biosimilars.

MARKET DYNAMICS
Drivers:

  •   Increasing R&D expenditures by biopharmaceutical companies and rising outsourcing activities.
  •   Increasing number of clinical trials because of rising pool of novel drug candidates.
  •   Growing demand for biosimilar and generic medicines is also expected to create significant growth opportunities for the market.

Restraints:

  •   However, presence of stringent regulatory framework along with complexities asociated with service are likely to restrain market growth during the forecast period.


RD Image
  • Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
  • Request discounts available for Start-Ups & Universities
REGIONAL FRAMEWORK


The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides an overview and forecast of the global market based on various segments. It also provides market size and forecast estimates from the year 2019 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), the Middle East and Africa (MEA), and South America. The biopharmaceutical CMO and CRO market by each region is later sub-segmented by respective countries and segments. The report covers the analysis and forecast of 18 countries globally along with the current trend and opportunities prevailing in the region.

The report analyzes factors affecting the market from both demand and supply side and further evaluates market dynamics affecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA, and South America after evaluating political, economic, social and technological factors affecting the biopharmaceutical CMO and CRO market in these regions.

IMPACT OF COVID-19 ON BIOPHARMACEUTICAL CMO AND CRO MARKET

COVID-19 first began in Wuhan (China) during December 2019 and since then it has spread at a fast pace across the globe. The US, India, Brazil, Russia, France, the UK, Turkey, Italy, and Spain are some of the worst affected countries in terms confirmed cases and reported deaths. The COVID-19 has been affecting economies and industries in various countries due to lockdowns, travel bans, and business shutdowns. Shutdown of various plants and factories has affected the global supply chains and negatively impacted the manufacturing, delivery schedules, and sales of products in global market. Few companies have already announced possible delays in product deliveries and slump in future sales of their products. According to the current market situation, the report further assesses the present and future effects of the COVID-19 pandemic on the overall market, giving more reliable and authentic projections In addition to this, the global travel bans imposed by countries in Europe, Asia-Pacific, and North America are affecting the business collaborations and partnerships opportunities.

World Geography

Have a question?

Analyst

Akshay

Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.

Analyst   Speak to Analyst
  • Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
  • Request discounts available for Start-Ups & Universities
MARKET PLAYERS


The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides an overview and forecast of the global market based on various segments. It also provides market size and forecast estimates from the year 2019 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), the Middle East and Africa (MEA), and South America. The biopharmaceutical CMO and CRO market by each region is later sub-segmented by respective countries and segments. The report covers the analysis and forecast of 18 countries globally along with the current trend and opportunities prevailing in the region.

The report analyzes factors affecting the market from both demand and supply side and further evaluates market dynamics affecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA, and South America after evaluating political, economic, social and technological factors affecting the biopharmaceutical CMO and CRO market in these regions.

IMPACT OF COVID-19 ON BIOPHARMACEUTICAL CMO AND CRO MARKET

COVID-19 first began in Wuhan (China) during December 2019 and since then it has spread at a fast pace across the globe. The US, India, Brazil, Russia, France, the UK, Turkey, Italy, and Spain are some of the worst affected countries in terms confirmed cases and reported deaths. The COVID-19 has been affecting economies and industries in various countries due to lockdowns, travel bans, and business shutdowns. Shutdown of various plants and factories has affected the global supply chains and negatively impacted the manufacturing, delivery schedules, and sales of products in global market. Few companies have already announced possible delays in product deliveries and slump in future sales of their products. According to the current market situation, the report further assesses the present and future effects of the COVID-19 pandemic on the overall market, giving more reliable and authentic projections In addition to this, the global travel bans imposed by countries in Europe, Asia-Pacific, and North America are affecting the business collaborations and partnerships opportunities.

MARKET PLAYERS

The report covers key developments in the biopharmaceutical CMO and CRO market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the marketwere acquisitions, and partnership & collaborations. These activities have paved way for the expansion of business and customer base of market players. The market payers from biopharmaceutical CMO and CRO market are anticipated to lucrative growth opportunities in the future with the rising demand for biopharmaceutical CMO and CRO in the global market.

The report also includes the profiles of key companies along with their SWOT analysis and market strategies in the biopharmaceutical CMO and CRO market. In addition, the report focuses on leading industry players with information such as company profiles, components, and services offered, financial information of the last 3 years, the key development in the past five years.

  •   AGC Biologics
  •   Boehringer Ingelheim International GmbH
  •   FUJIFILM Diosynth Biotechnologies U.S.A., Inc.
  •   TOYOBO CO., LTD
  •   JRS PHARMA
  •   Lonza
  •   PRA Health Sciences, Inc.
  •   ProBioGen AG
  •   Rentschler Biopharma SE
  •   Samsung BioLogics
The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.
  • Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
  • Request discounts available for Start-Ups & Universities
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Biopharmaceutical CMO And CRO Market - By Source
1.3.2 Biopharmaceutical CMO And CRO Market - By Service Type
1.3.3 Biopharmaceutical CMO And CRO Market - By Product
1.3.4 Biopharmaceutical CMO And CRO Market - By Region
1.3.4.1 By Country

2. KEY TAKEAWAYS

3. RESEARCH METHODOLOGY

4. BIOPHARMACEUTICAL CMO AND CRO MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PORTER'S FIVE FORCES ANALYSIS
4.2.1 Bargaining Power of Buyers
4.2.1 Bargaining Power of Suppliers
4.2.1 Threat of Substitute
4.2.1 Threat of New Entrants
4.2.1 Competitive Rivalry
4.3. EXPERT OPINIONS

5. BIOPHARMACEUTICAL CMO AND CRO MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS

6. BIOPHARMACEUTICAL CMO AND CRO MARKET - GLOBAL MARKET ANALYSIS
6.1. BIOPHARMACEUTICAL CMO AND CRO - GLOBAL MARKET OVERVIEW
6.2. BIOPHARMACEUTICAL CMO AND CRO - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING/MARKET SHARE

7. BIOPHARMACEUTICAL CMO AND CRO MARKET - REVENUE AND FORECASTS TO 2028 - SOURCE
7.1. OVERVIEW
7.2. SOURCE MARKET FORECASTS AND ANALYSIS
7.3. MAMMALIAN
7.3.1. Overview
7.3.2. Mammalian Market Forecast and Analysis
7.4. NON-MAMMALIAN
7.4.1. Overview
7.4.2. Non-Mammalian Market Forecast and Analysis
8. BIOPHARMACEUTICAL CMO AND CRO MARKET - REVENUE AND FORECASTS TO 2028 - SERVICE TYPE
8.1. OVERVIEW
8.2. SERVICE TYPE MARKET FORECASTS AND ANALYSIS
8.3. CONTRACT MANUFACTURING
8.3.1. Overview
8.3.2. Contract Manufacturing Market Forecast and Analysis
8.3.3. Analytical and QC studies Market
8.3.3.1. Overview
8.3.3.2. Analytical and QC studies Market Forecast and Analysis
8.3.4. Fill and Finish Operations Market
8.3.4.1. Overview
8.3.4.2. Fill and Finish Operations Market Forecast and Analysis
8.3.5. Packaging Market
8.3.5.1. Overview
8.3.5.2. Packaging Market Forecast and Analysis
8.3.6. Process Development Market
8.3.6.1. Overview
8.3.6.2. Process Development Market Forecast and Analysis
8.4. CONTRACT RESEARCH
8.4.1. Overview
8.4.2. Contract Research Market Forecast and Analysis
8.4.3. Cardiology Market
8.4.3.1. Overview
8.4.3.2. Cardiology Market Forecast and Analysis
8.4.4. Inflammation and Immunology Market
8.4.4.1. Overview
8.4.4.2. Inflammation and Immunology Market Forecast and Analysis
8.4.5. Neuroscience Market
8.4.5.1. Overview
8.4.5.2. Neuroscience Market Forecast and Analysis
8.4.6. Oncology Market
8.4.6.1. Overview
8.4.6.2. Oncology Market Forecast and Analysis
8.4.7. Other Types Market
8.4.7.1. Overview
8.4.7.2. Other Types Market Forecast and Analysis
9. BIOPHARMACEUTICAL CMO AND CRO MARKET - REVENUE AND FORECASTS TO 2028 - PRODUCT
9.1. OVERVIEW
9.2. PRODUCT MARKET FORECASTS AND ANALYSIS
9.3. BIOLOGICS
9.3.1. Overview
9.3.2. Biologics Market Forecast and Analysis
9.3.3. Antisense RNAi Market
9.3.3.1. Overview
9.3.3.2. Antisense RNAi Market Forecast and Analysis
9.3.4. and Molecular Therapy Market
9.3.4.1. Overview
9.3.4.2. and Molecular Therapy Market Forecast and Analysis
9.3.5. Monoclonal Antibodies (MAbs) Market
9.3.5.1. Overview
9.3.5.2. Monoclonal Antibodies (MAbs) Market Forecast and Analysis
9.3.6. Recombinant Proteins Market
9.3.6.1. Overview
9.3.6.2. Recombinant Proteins Market Forecast and Analysis
9.3.7. Vaccines Market
9.3.7.1. Overview
9.3.7.2. Vaccines Market Forecast and Analysis
9.3.8. Other Biologics Market
9.3.8.1. Overview
9.3.8.2. Other Biologics Market Forecast and Analysis
9.4. BIOSIMILARS
9.4.1. Overview
9.4.2. Biosimilars Market Forecast and Analysis

10. BIOPHARMACEUTICAL CMO AND CRO MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
10.1. NORTH AMERICA
10.1.1 North America Biopharmaceutical CMO And CRO Market Overview
10.1.2 North America Biopharmaceutical CMO And CRO Market Forecasts and Analysis
10.1.3 North America Biopharmaceutical CMO And CRO Market Forecasts and Analysis - By Source
10.1.4 North America Biopharmaceutical CMO And CRO Market Forecasts and Analysis - By Service Type
10.1.5 North America Biopharmaceutical CMO And CRO Market Forecasts and Analysis - By Product
10.1.6 North America Biopharmaceutical CMO And CRO Market Forecasts and Analysis - By Countries
10.1.6.1 United States Biopharmaceutical CMO And CRO Market
10.1.6.1.1 United States Biopharmaceutical CMO And CRO Market by Source
10.1.6.1.2 United States Biopharmaceutical CMO And CRO Market by Service Type
10.1.6.1.3 United States Biopharmaceutical CMO And CRO Market by Product
10.1.6.2 Canada Biopharmaceutical CMO And CRO Market
10.1.6.2.1 Canada Biopharmaceutical CMO And CRO Market by Source
10.1.6.2.2 Canada Biopharmaceutical CMO And CRO Market by Service Type
10.1.6.2.3 Canada Biopharmaceutical CMO And CRO Market by Product
10.1.6.3 Mexico Biopharmaceutical CMO And CRO Market
10.1.6.3.1 Mexico Biopharmaceutical CMO And CRO Market by Source
10.1.6.3.2 Mexico Biopharmaceutical CMO And CRO Market by Service Type
10.1.6.3.3 Mexico Biopharmaceutical CMO And CRO Market by Product
10.2. EUROPE
10.2.1 Europe Biopharmaceutical CMO And CRO Market Overview
10.2.2 Europe Biopharmaceutical CMO And CRO Market Forecasts and Analysis
10.2.3 Europe Biopharmaceutical CMO And CRO Market Forecasts and Analysis - By Source
10.2.4 Europe Biopharmaceutical CMO And CRO Market Forecasts and Analysis - By Service Type
10.2.5 Europe Biopharmaceutical CMO And CRO Market Forecasts and Analysis - By Product
10.2.6 Europe Biopharmaceutical CMO And CRO Market Forecasts and Analysis - By Countries
10.2.6.1 Germany Biopharmaceutical CMO And CRO Market
10.2.6.1.1 Germany Biopharmaceutical CMO And CRO Market by Source
10.2.6.1.2 Germany Biopharmaceutical CMO And CRO Market by Service Type
10.2.6.1.3 Germany Biopharmaceutical CMO And CRO Market by Product
10.2.6.2 France Biopharmaceutical CMO And CRO Market
10.2.6.2.1 France Biopharmaceutical CMO And CRO Market by Source
10.2.6.2.2 France Biopharmaceutical CMO And CRO Market by Service Type
10.2.6.2.3 France Biopharmaceutical CMO And CRO Market by Product
10.2.6.3 Italy Biopharmaceutical CMO And CRO Market
10.2.6.3.1 Italy Biopharmaceutical CMO And CRO Market by Source
10.2.6.3.2 Italy Biopharmaceutical CMO And CRO Market by Service Type
10.2.6.3.3 Italy Biopharmaceutical CMO And CRO Market by Product
10.2.6.4 Spain Biopharmaceutical CMO And CRO Market
10.2.6.4.1 Spain Biopharmaceutical CMO And CRO Market by Source
10.2.6.4.2 Spain Biopharmaceutical CMO And CRO Market by Service Type
10.2.6.4.3 Spain Biopharmaceutical CMO And CRO Market by Product
10.2.6.5 United Kingdom Biopharmaceutical CMO And CRO Market
10.2.6.5.1 United Kingdom Biopharmaceutical CMO And CRO Market by Source
10.2.6.5.2 United Kingdom Biopharmaceutical CMO And CRO Market by Service Type
10.2.6.5.3 United Kingdom Biopharmaceutical CMO And CRO Market by Product
10.2.6.6 Rest of Europe Biopharmaceutical CMO And CRO Market
10.2.6.6.1 Rest of Europe Biopharmaceutical CMO And CRO Market by Source
10.2.6.6.2 Rest of Europe Biopharmaceutical CMO And CRO Market by Service Type
10.2.6.6.3 Rest of Europe Biopharmaceutical CMO And CRO Market by Product
10.3. ASIA-PACIFIC
10.3.1 Asia-Pacific Biopharmaceutical CMO And CRO Market Overview
10.3.2 Asia-Pacific Biopharmaceutical CMO And CRO Market Forecasts and Analysis
10.3.3 Asia-Pacific Biopharmaceutical CMO And CRO Market Forecasts and Analysis - By Source
10.3.4 Asia-Pacific Biopharmaceutical CMO And CRO Market Forecasts and Analysis - By Service Type
10.3.5 Asia-Pacific Biopharmaceutical CMO And CRO Market Forecasts and Analysis - By Product
10.3.6 Asia-Pacific Biopharmaceutical CMO And CRO Market Forecasts and Analysis - By Countries
10.3.6.1 Australia Biopharmaceutical CMO And CRO Market
10.3.6.1.1 Australia Biopharmaceutical CMO And CRO Market by Source
10.3.6.1.2 Australia Biopharmaceutical CMO And CRO Market by Service Type
10.3.6.1.3 Australia Biopharmaceutical CMO And CRO Market by Product
10.3.6.2 China Biopharmaceutical CMO And CRO Market
10.3.6.2.1 China Biopharmaceutical CMO And CRO Market by Source
10.3.6.2.2 China Biopharmaceutical CMO And CRO Market by Service Type
10.3.6.2.3 China Biopharmaceutical CMO And CRO Market by Product
10.3.6.3 India Biopharmaceutical CMO And CRO Market
10.3.6.3.1 India Biopharmaceutical CMO And CRO Market by Source
10.3.6.3.2 India Biopharmaceutical CMO And CRO Market by Service Type
10.3.6.3.3 India Biopharmaceutical CMO And CRO Market by Product
10.3.6.4 Japan Biopharmaceutical CMO And CRO Market
10.3.6.4.1 Japan Biopharmaceutical CMO And CRO Market by Source
10.3.6.4.2 Japan Biopharmaceutical CMO And CRO Market by Service Type
10.3.6.4.3 Japan Biopharmaceutical CMO And CRO Market by Product
10.3.6.5 South Korea Biopharmaceutical CMO And CRO Market
10.3.6.5.1 South Korea Biopharmaceutical CMO And CRO Market by Source
10.3.6.5.2 South Korea Biopharmaceutical CMO And CRO Market by Service Type
10.3.6.5.3 South Korea Biopharmaceutical CMO And CRO Market by Product
10.3.6.6 Rest of Asia-Pacific Biopharmaceutical CMO And CRO Market
10.3.6.6.1 Rest of Asia-Pacific Biopharmaceutical CMO And CRO Market by Source
10.3.6.6.2 Rest of Asia-Pacific Biopharmaceutical CMO And CRO Market by Service Type
10.3.6.6.3 Rest of Asia-Pacific Biopharmaceutical CMO And CRO Market by Product
10.4. MIDDLE EAST AND AFRICA
10.4.1 Middle East and Africa Biopharmaceutical CMO And CRO Market Overview
10.4.2 Middle East and Africa Biopharmaceutical CMO And CRO Market Forecasts and Analysis
10.4.3 Middle East and Africa Biopharmaceutical CMO And CRO Market Forecasts and Analysis - By Source
10.4.4 Middle East and Africa Biopharmaceutical CMO And CRO Market Forecasts and Analysis - By Service Type
10.4.5 Middle East and Africa Biopharmaceutical CMO And CRO Market Forecasts and Analysis - By Product
10.4.6 Middle East and Africa Biopharmaceutical CMO And CRO Market Forecasts and Analysis - By Countries
10.4.6.1 South Africa Biopharmaceutical CMO And CRO Market
10.4.6.1.1 South Africa Biopharmaceutical CMO And CRO Market by Source
10.4.6.1.2 South Africa Biopharmaceutical CMO And CRO Market by Service Type
10.4.6.1.3 South Africa Biopharmaceutical CMO And CRO Market by Product
10.4.6.2 Saudi Arabia Biopharmaceutical CMO And CRO Market
10.4.6.2.1 Saudi Arabia Biopharmaceutical CMO And CRO Market by Source
10.4.6.2.2 Saudi Arabia Biopharmaceutical CMO And CRO Market by Service Type
10.4.6.2.3 Saudi Arabia Biopharmaceutical CMO And CRO Market by Product
10.4.6.3 U.A.E Biopharmaceutical CMO And CRO Market
10.4.6.3.1 U.A.E Biopharmaceutical CMO And CRO Market by Source
10.4.6.3.2 U.A.E Biopharmaceutical CMO And CRO Market by Service Type
10.4.6.3.3 U.A.E Biopharmaceutical CMO And CRO Market by Product
10.4.6.4 Rest of Middle East and Africa Biopharmaceutical CMO And CRO Market
10.4.6.4.1 Rest of Middle East and Africa Biopharmaceutical CMO And CRO Market by Source
10.4.6.4.2 Rest of Middle East and Africa Biopharmaceutical CMO And CRO Market by Service Type
10.4.6.4.3 Rest of Middle East and Africa Biopharmaceutical CMO And CRO Market by Product
10.5. SOUTH AND CENTRAL AMERICA
10.5.1 South and Central America Biopharmaceutical CMO And CRO Market Overview
10.5.2 South and Central America Biopharmaceutical CMO And CRO Market Forecasts and Analysis
10.5.3 South and Central America Biopharmaceutical CMO And CRO Market Forecasts and Analysis - By Source
10.5.4 South and Central America Biopharmaceutical CMO And CRO Market Forecasts and Analysis - By Service Type
10.5.5 South and Central America Biopharmaceutical CMO And CRO Market Forecasts and Analysis - By Product
10.5.6 South and Central America Biopharmaceutical CMO And CRO Market Forecasts and Analysis - By Countries
10.5.6.1 Brazil Biopharmaceutical CMO And CRO Market
10.5.6.1.1 Brazil Biopharmaceutical CMO And CRO Market by Source
10.5.6.1.2 Brazil Biopharmaceutical CMO And CRO Market by Service Type
10.5.6.1.3 Brazil Biopharmaceutical CMO And CRO Market by Product
10.5.6.2 Argentina Biopharmaceutical CMO And CRO Market
10.5.6.2.1 Argentina Biopharmaceutical CMO And CRO Market by Source
10.5.6.2.2 Argentina Biopharmaceutical CMO And CRO Market by Service Type
10.5.6.2.3 Argentina Biopharmaceutical CMO And CRO Market by Product
10.5.6.3 Rest of South and Central America Biopharmaceutical CMO And CRO Market
10.5.6.3.1 Rest of South and Central America Biopharmaceutical CMO And CRO Market by Source
10.5.6.3.2 Rest of South and Central America Biopharmaceutical CMO And CRO Market by Service Type
10.5.6.3.3 Rest of South and Central America Biopharmaceutical CMO And CRO Market by Product

11. INDUSTRY LANDSCAPE
11.1. MERGERS AND ACQUISITIONS
11.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
11.3. NEW PRODUCT LAUNCHES
11.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS

12. BIOPHARMACEUTICAL CMO AND CRO MARKET, KEY COMPANY PROFILES
12.1. AGC BIOLOGICS
12.1.1. Key Facts
12.1.2. Business Description
12.1.3. Products and Services
12.1.4. Financial Overview
12.1.5. SWOT Analysis
12.1.6. Key Developments
12.2. BOEHRINGER INGELHEIM INTERNATIONAL GMBH
12.2.1. Key Facts
12.2.2. Business Description
12.2.3. Products and Services
12.2.4. Financial Overview
12.2.5. SWOT Analysis
12.2.6. Key Developments
12.3. FUJIFILM DIOSYNTH BIOTECHNOLOGIES U.S.A., INC.
12.3.1. Key Facts
12.3.2. Business Description
12.3.3. Products and Services
12.3.4. Financial Overview
12.3.5. SWOT Analysis
12.3.6. Key Developments
12.4. TOYOBO CO., LTD
12.4.1. Key Facts
12.4.2. Business Description
12.4.3. Products and Services
12.4.4. Financial Overview
12.4.5. SWOT Analysis
12.4.6. Key Developments
12.5. JRS PHARMA
12.5.1. Key Facts
12.5.2. Business Description
12.5.3. Products and Services
12.5.4. Financial Overview
12.5.5. SWOT Analysis
12.5.6. Key Developments
12.6. LONZA
12.6.1. Key Facts
12.6.2. Business Description
12.6.3. Products and Services
12.6.4. Financial Overview
12.6.5. SWOT Analysis
12.6.6. Key Developments
12.7. PRA HEALTH SCIENCES, INC.
12.7.1. Key Facts
12.7.2. Business Description
12.7.3. Products and Services
12.7.4. Financial Overview
12.7.5. SWOT Analysis
12.7.6. Key Developments
12.8. PROBIOGEN AG
12.8.1. Key Facts
12.8.2. Business Description
12.8.3. Products and Services
12.8.4. Financial Overview
12.8.5. SWOT Analysis
12.8.6. Key Developments
12.9. RENTSCHLER BIOPHARMA SE
12.9.1. Key Facts
12.9.2. Business Description
12.9.3. Products and Services
12.9.4. Financial Overview
12.9.5. SWOT Analysis
12.9.6. Key Developments
12.10. SAMSUNG BIOLOGICS
12.10.1. Key Facts
12.10.2. Business Description
12.10.3. Products and Services
12.10.4. Financial Overview
12.10.5. SWOT Analysis
12.10.6. Key Developments

13. APPENDIX
13.1. ABOUT THE INSIGHT PARTNERS
13.2. GLOSSARY OF TERMS
The List of Companies

1. AGC Biologics
2. Boehringer Ingelheim International GmbH
3. FUJIFILM Diosynth Biotechnologies U.S.A., Inc.
4. TOYOBO CO., LTD
5. JRS PHARMA
6. Lonza
7. PRA Health Sciences, Inc.
8. ProBioGen AG
9. Rentschler Biopharma SE
10. Samsung BioLogics

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • 3.1 Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • 3.2 Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • 3.3 Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • 3.4 Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Trends and growth analysis reports related to Biopharmaceutical CMO and CRO Market